4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-026210
Options or other derivatives
- Chief Financial Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2017-11-13 | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | D | ||
Loading xslF345X03/doc4.xml…